Starling Oncology has rebranded from The Oncology Institute and introduced a new technology platform to help its community-based clinics deliver the coordinated, high-quality cancer care that patients expect from a top California oncology program.
LOS ANGELES, Sept. 30, 2026 /PRNewswire-PRWeb/ -- Community-based cancer treatment providerStarling Oncology, formerly The Oncology Institute, has completed a company-wide rebrand alongside launching Starling Nexus™, a proprietary technology platform to streamline prior authorizations and clinical decision-making for oncology teams. The dual announcement signals a new phase for the provider, helping it stand out among the top oncology centers in Southern California by building around faster, more coordinated access to cancer treatment.
The rebrand mirrors a shift already underway at the organization, moving from a traditional oncology practice into what leadership describes as an integrated care platform serving patients, providers and health plans across several states, with a strong concentration of clinics and network locations throughout Southern California. According to the organization, the new name reflects the coordinated, team-based nature of its care delivery model, likened to the flight pattern of starlings moving in unison.
What Does the Rebrand Signal for Patients Searching for Top California Oncology Programs?
Patients researching the best cancer hospitals in California are increasingly weighing both clinical reputation and how efficiently a program can move someone from diagnosis to treatment. Starling Oncology has built its identity around addressing that gap directly, emphasizing high-quality, outcomes-focused cancer care delivered in community settings rather than solely within large academic medical centers. Its programs include outpatient transfusions, an active clinical trials program, and coordinated services designed to keep patients closer to home during treatment.
Central to that promise is Starling Nexus™, which unifies clinical decision support, evidence-based treatment pathways and prior-authorization workflows into a single provider-facing tool. The platform is designed to compress prior-authorization timelines, so clinicians spend more time on care decisions and less on paperwork. It also reflects the organization's broader emphasis on measurable outcomes rather than volume, an approach tied directly to care quality rather than cost alone.
"Our name is changing, but our mission remains steadfast," says Dan Virnich, MD, Chief Executive Officer of Starling Oncology, describing the transition. The organization has also built recognition through its Patient Safety Organization designation, one ofmore than 100 nationwide, reflecting a structured, data-driven approach to identifying and reducing care risks across its network.
About Starling Oncology
Starling Oncology, formerly The Oncology Institute, is a community-based oncology provider offering specialized cancer care, including outpatient transfusions and clinical trial access, across a network of clinics and locations spanning several states. The organization holds a Patient Safety Organization designation, one of over 100 such distinctions nationwide, reflecting its structured approach to quality of care. Starling Oncology continues to coordinate access to cancer treatment for patients across the communities it serves.
Media Contact
Shane Jones, Starling Oncology, 1 (717) 928-0683, [email protected], https://starlingoncology.com/
SOURCE Starling Oncology
Share this article